Compounds > alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and oxidopamine

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with oxidopamine in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (50.00)	18.2507
2000's	3 (30.00)	29.6817
2010's	2 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kunow, M; Löschmann, PA; Wachtel, H	1
Boldry, RC; Layer, RT; Uretsky, NJ; Wallace, LJ	1
Honoré, T; Jähnig, P; Jenner, P; Kunow, M; Lange, KW; Löschmann, PA; Marsden, CD; Rettig, KJ; Turski, L; Wachtel, H	1
Ossowska, K	1
Dewar, KM; Elie, R; Vasiliadis, HM	1
Baumbarger, P; Bleakman, D; Gates, M; Hicks, CA; Lodge, D; Murray, TK; Nisenbaum, ES; O'Neill, MJ; Ogden, AM; Robinson, CS; Siuda, E; Skolnick, P; Vandergriff, JL; Ward, MA; Whalley, K; Zimmerman, DM	1
Bianchi, L; Bolam, JP; Della Corte, L; Galeffi, F	1
Alonso, TJ; Castro Fuentes, R; García Dopico, J; González Hernández, T; Perdomo Díaz, J; Rodríguez Díaz, M	1
Kreitzer, AC; Lalive, AL; Parker, PR	1
Dragon, DN; Lin, LH; Talman, WT	1

Reviews

1 review(s) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and oxidopamine

Article	Year
The role of excitatory amino acids in experimental models of Parkinson's disease. Journal of neural transmission. Parkinson's disease and dementia section, 1994, Volume: 8, Issue:1-2 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Catalepsy; Disease Models, Animal; Excitatory Amino Acids; Levodopa; N-Methylaspartate; Oxidopamine; Parkinson Disease; Rats	1994

Other Studies

9 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and oxidopamine

Article	Year
NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats. Neuroscience letters, 1992, Aug-17, Volume: 142, Issue:2 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Apomorphine; Dopamine Agents; Drug Synergism; Ibotenic Acid; Lisuride; Male; Neurons; Oxidopamine; Parkinson Disease, Secondary; Piperazines; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Substantia Nigra; Sympathectomy, Chemical	1992
Stimulation of locomotor activity by intra-accumbens AMPA is not inhibited by neonatal 6-hydroxydopamine-induced lesions. Neuroscience letters, 1992, Apr-27, Volume: 138, Issue:2 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Animals, Newborn; Ibotenic Acid; Injections; Motor Activity; Nucleus Accumbens; Oxidopamine; Rats; Rats, Inbred Strains	1992
Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease. Journal of neural transmission. Parkinson's disease and dementia section, 1991, Volume: 3, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Callithrix; Disease Models, Animal; Drug Synergism; Ibotenic Acid; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Piperazines; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Substantia Nigra	1991
Interaction between dopamine and glutamate receptors following treatment with NMDA receptor antagonists. European journal of pharmacology, 1999, Dec-15, Volume: 386, Issue:2-3 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzamides; Benzazepines; Dizocilpine Maleate; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Female; Oxidopamine; Piperazines; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptors, AMPA; Receptors, Dopamine; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Tritium	1999
LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease. The Journal of pharmacology and experimental therapeutics, 2003, Volume: 306, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amides; Animals; Biphenyl Compounds; Cells, Cultured; Corpus Striatum; Dioxoles; Disease Models, Animal; Excitatory Amino Acid Agonists; GAP-43 Protein; Hippocampus; Humans; Male; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Glutamate; Substantia Nigra	2003
The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis. The European journal of neuroscience, 2003, Volume: 18, Issue:4 Topics: Adrenergic Agents; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Basal Ganglia; Chromatography, High Pressure Liquid; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Immunohistochemistry; Injections, Intraventricular; Kainic Acid; Male; Microdialysis; Models, Animal; Oxidopamine; Parkinson Disease; Potassium; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase	2003
Extracellular taurine in the substantia nigra: taurine-glutamate interaction. Journal of neuroscience research, 2004, May-15, Volume: 76, Issue:4 Topics: Adrenergic Agents; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Brain Chemistry; Calcium; Chelating Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Excitatory Amino Acid Antagonists; Extracellular Space; gamma-Aminobutyric Acid; Glutamic Acid; Kainic Acid; Ketamine; Male; Membrane Potentials; Microdialysis; N-Methylaspartate; Oxidopamine; Potassium; Rats; Rats, Sprague-Dawley; Substantia Nigra; Taurine; Time Factors; Zinc	2004
Pathway-Specific Remodeling of Thalamostriatal Synapses in Parkinsonian Mice. Neuron, 2016, Feb-17, Volume: 89, Issue:4 Topics: Adrenergic Agents; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Corpus Striatum; Disease Models, Animal; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Exploratory Behavior; Functional Laterality; Homeodomain Proteins; Medial Forebrain Bundle; Mice; N-Methylaspartate; Neural Pathways; Oxidopamine; Parkinsonian Disorders; Synapses; Thalamus; Transcription Factors; Tyrosine 3-Monooxygenase; Vesicular Glutamate Transport Protein 2	2016
Reduced responses to glutamate receptor agonists follow loss of astrocytes and astroglial glutamate markers in the nucleus tractus solitarii. Physiological reports, 2017, Volume: 5, Issue:5 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Arterial Pressure; Astrocytes; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Transporter 2; Excitatory Amino Acid Transporter 3; Heart Rate; Immunotoxins; Male; N-Methylaspartate; Neurons; Oxidopamine; Rats; Rats, Sprague-Dawley; Ribosome Inactivating Proteins, Type 1; Saporins; Solitary Nucleus; Synaptic Transmission; Vesicular Glutamate Transport Protein 2	2017